Reported Consolidated quarterly numbers for Panacea Biotec are:
Net Sales at Rs 150.50 crore in December 2023 up 30.64% from Rs. 115.20 crore in December 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 2.20 crore in December 2023 down 111.36% from Rs. 19.37 crore in December 2022.
EBITDA stands at Rs. 5.53 crore in December 2023 up 4.34% from Rs. 5.30 crore in December 2022.
Panacea Biotec shares closed at 162.45 on February 23, 2024 (NSE) and has given 22.28% returns over the last 6 months and 32.77% over the last 12 months.
Story continues below Advertisement
| Panacea Biotec | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 150.50 | 143.02 | 115.20 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 150.50 | 143.02 | 115.20 | | EXPENDITURE | | Consumption of Raw Materials | 47.83 | 59.78 | 48.07 | | Purchase of Traded Goods | 1.09 | -- | 1.96 | | Increase/Decrease in Stocks | 18.40 | -1.59 | -2.25 | | Power & Fuel | -- | -- | -- | | Employees Cost | 37.65 | 37.52 | 32.02 | | Depreciation | 9.11 | 9.31 | -16.55 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 45.68 | 50.87 | 44.04 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -9.26 | -12.87 | 7.91 | | Other Income | 5.68 | 3.23 | 13.94 | | P/L Before Int., Excpt. Items & Tax | -3.58 | -9.64 | 21.85 | | Interest | 0.85 | 0.91 | 27.18 | | P/L Before Exceptional Items & Tax | -4.43 | -10.55 | -5.33 | | Exceptional Items | 2.78 | 2.77 | 27.77 | | P/L Before Tax | -1.65 | -7.78 | 22.44 | | Tax | 0.55 | 0.51 | 3.07 | | P/L After Tax from Ordinary Activities | -2.20 | -8.29 | 19.37 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -2.20 | -8.29 | 19.37 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -2.20 | -8.29 | 19.37 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.37 | -1.35 | 3.16 | | Diluted EPS | -0.37 | -1.35 | 3.16 | | EPS After Extra Ordinary | | Basic EPS | -0.37 | -1.35 | 3.16 | | Diluted EPS | -0.37 | -1.35 | 3.16 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
